The enactment of laws regulating the use of cannabis by adults is associated with short-term declines in self-reported marijuana use by young people, according to findings published today in the journal JAMA Pediatrics.
Drivers testing positive for the presence of THC in blood do not possess a significantly increased risk of being responsible for a non-fatal motor vehicle accident, according to data published in the journal Addiction.
The administration of oral CBD reduces cue-induced cravings and anxiety in subjects with a history of heroin use, according to clinical data published in The American Journal of Psychiatry. Commenting on the study’s findings, NORML Deputy Director Paul Armentano said, “These conclusions add to the growing body of evidence that cannabis and its constituents represent an exit away from the use or abuse of other controlled substances rather than a supposed ‘gateway.'”
Marijuana grown by the University of Mississippi for clinical research purposes is genetically divergent from strains of cannabis commercially available in retail markets, according to an analysis prepared by researchers at the University of Northern Colorado.
Cannabis exposure is not associated with significant changes in brain morphology in either older or younger subjects, according to a pair of newly published studies.
Patients authorized to legally use medical cannabis frequently substitute it in place of benzodiazepines, according to a pair of new studies published this week. According to data compiled by the US Centers for Disease Control, the use of benzodiazepines were attributed to over 11,500 overdose deaths in 2017.
Representatives Lou Correa (D-CA) and Clay Higgins (R-LA) and Senators Jon Tester (D-MT) and Dan Sullivan (R-AK) have introduced legislation, HR 712 / S. 179: The VA Medicinal Cannabis Research Act of 2019 to facilitate federally-sponsored clinical research into the safety and efficacy of medical cannabis among veterans.
The total number of peer-reviewed scientific papers dedicated to cannabis, and the therapeutic use of cannabis in particular, has increased exponentially in recent years, according to data published the journal Population Health Management. Authors identified just over 29,000 cannabis-centric scientific papers published during the study period, with over 3,300 of those dedicated to the subject of medical marijuana.
NORML chapters around the country are working to protect honest, hardworking marijuana consumers from discriminatory workplace drug-testing practices, in particular, the use of random suspicionless urine testing. By emphasizing the importance of impairment detection and workplace safety, we can reframe the conversation to focus on creating a 21st century workplace that’s free of impairment while protecting individual rights.